4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats

Laura Wright, Jennifer B. Frye, Ashley L. Lukefahr, Samuel L. Marion, Patricia B. Hoyer, David G. Besselsen, Janet L. Funk

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that targets ovarian follicles and accelerates ovarian failure in rodents, was used to test the effect of early-onset reproductive senescence on mammary fibroadenoma formation. One-month female Sprague Dawley rats were dosed with VCD (80. mg/kg or 160. mg/kg) and monitored for 22 months for persistent estrus and tumor development. Only high-dose VCD treatment accelerated the onset of persistent estrus relative to controls. However, both doses of VCD accelerated mammary tumor onset by 5 months, increasing incidence to 84% (vs. 38% in controls). Tumor development was independent of time in persistent estrus, 17β-estradiol, androstenedione and prolactin. Delay in VCD administration until after completion of mammary epithelial differentiation (3 months) did not alter tumor formation despite acceleration of ovarian senescence. VCD administration to 1-month rats acutely decreased mammary alveolar bud number and expression of β-casein, suggesting that VCD's tumorigenic effect requires exposure during mammary epithelial differentiation.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalReproductive Toxicology
Volume32
Issue number1
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Fibroadenoma
Sprague Dawley Rats
Rats
Breast
Tumors
Estrus
Neoplasms
Ovarian Follicle
Androstenedione
Caseins
Prolactin
4-vinyl-1-cyclohexene dioxide
Estradiol
Rodentia
Breast Neoplasms
Incidence

Keywords

  • β-Casein
  • C-KIT
  • Fibroadenoma
  • Mammary epithelium
  • VCD

ASJC Scopus subject areas

  • Toxicology

Cite this

4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats. / Wright, Laura; Frye, Jennifer B.; Lukefahr, Ashley L.; Marion, Samuel L.; Hoyer, Patricia B.; Besselsen, David G.; Funk, Janet L.

In: Reproductive Toxicology, Vol. 32, No. 1, 07.2011, p. 26-32.

Research output: Contribution to journalArticle

Wright, Laura ; Frye, Jennifer B. ; Lukefahr, Ashley L. ; Marion, Samuel L. ; Hoyer, Patricia B. ; Besselsen, David G. ; Funk, Janet L. / 4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats. In: Reproductive Toxicology. 2011 ; Vol. 32, No. 1. pp. 26-32.
@article{952cf8ae59e44ce6a164cf9362a8eb7e,
title = "4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats",
abstract = "4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that targets ovarian follicles and accelerates ovarian failure in rodents, was used to test the effect of early-onset reproductive senescence on mammary fibroadenoma formation. One-month female Sprague Dawley rats were dosed with VCD (80. mg/kg or 160. mg/kg) and monitored for 22 months for persistent estrus and tumor development. Only high-dose VCD treatment accelerated the onset of persistent estrus relative to controls. However, both doses of VCD accelerated mammary tumor onset by 5 months, increasing incidence to 84{\%} (vs. 38{\%} in controls). Tumor development was independent of time in persistent estrus, 17β-estradiol, androstenedione and prolactin. Delay in VCD administration until after completion of mammary epithelial differentiation (3 months) did not alter tumor formation despite acceleration of ovarian senescence. VCD administration to 1-month rats acutely decreased mammary alveolar bud number and expression of β-casein, suggesting that VCD's tumorigenic effect requires exposure during mammary epithelial differentiation.",
keywords = "β-Casein, C-KIT, Fibroadenoma, Mammary epithelium, VCD",
author = "Laura Wright and Frye, {Jennifer B.} and Lukefahr, {Ashley L.} and Marion, {Samuel L.} and Hoyer, {Patricia B.} and Besselsen, {David G.} and Funk, {Janet L.}",
year = "2011",
month = "7",
doi = "10.1016/j.reprotox.2011.05.005",
language = "English (US)",
volume = "32",
pages = "26--32",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - 4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats

AU - Wright, Laura

AU - Frye, Jennifer B.

AU - Lukefahr, Ashley L.

AU - Marion, Samuel L.

AU - Hoyer, Patricia B.

AU - Besselsen, David G.

AU - Funk, Janet L.

PY - 2011/7

Y1 - 2011/7

N2 - 4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that targets ovarian follicles and accelerates ovarian failure in rodents, was used to test the effect of early-onset reproductive senescence on mammary fibroadenoma formation. One-month female Sprague Dawley rats were dosed with VCD (80. mg/kg or 160. mg/kg) and monitored for 22 months for persistent estrus and tumor development. Only high-dose VCD treatment accelerated the onset of persistent estrus relative to controls. However, both doses of VCD accelerated mammary tumor onset by 5 months, increasing incidence to 84% (vs. 38% in controls). Tumor development was independent of time in persistent estrus, 17β-estradiol, androstenedione and prolactin. Delay in VCD administration until after completion of mammary epithelial differentiation (3 months) did not alter tumor formation despite acceleration of ovarian senescence. VCD administration to 1-month rats acutely decreased mammary alveolar bud number and expression of β-casein, suggesting that VCD's tumorigenic effect requires exposure during mammary epithelial differentiation.

AB - 4-Vinylcyclohexene diepoxide (VCD), an occupational chemical that targets ovarian follicles and accelerates ovarian failure in rodents, was used to test the effect of early-onset reproductive senescence on mammary fibroadenoma formation. One-month female Sprague Dawley rats were dosed with VCD (80. mg/kg or 160. mg/kg) and monitored for 22 months for persistent estrus and tumor development. Only high-dose VCD treatment accelerated the onset of persistent estrus relative to controls. However, both doses of VCD accelerated mammary tumor onset by 5 months, increasing incidence to 84% (vs. 38% in controls). Tumor development was independent of time in persistent estrus, 17β-estradiol, androstenedione and prolactin. Delay in VCD administration until after completion of mammary epithelial differentiation (3 months) did not alter tumor formation despite acceleration of ovarian senescence. VCD administration to 1-month rats acutely decreased mammary alveolar bud number and expression of β-casein, suggesting that VCD's tumorigenic effect requires exposure during mammary epithelial differentiation.

KW - β-Casein

KW - C-KIT

KW - Fibroadenoma

KW - Mammary epithelium

KW - VCD

UR - http://www.scopus.com/inward/record.url?scp=79960470554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960470554&partnerID=8YFLogxK

U2 - 10.1016/j.reprotox.2011.05.005

DO - 10.1016/j.reprotox.2011.05.005

M3 - Article

C2 - 21621605

AN - SCOPUS:79960470554

VL - 32

SP - 26

EP - 32

JO - Reproductigve Toxicoloy

JF - Reproductigve Toxicoloy

SN - 0890-6238

IS - 1

ER -